• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9-甲氧基喜树碱在选定癌细胞系中的体外抗癌活性及作用机制。

The In Vitro Anti-Cancer Activities and Mechanisms of Action of 9-Methoxycanthin-6-one from in Selected Cancer Cell Lines.

机构信息

Bioactivity Programme, Natural Products Division, Forest Research Institute Malaysia, Kepong 52109, Malaysia.

Phytochemistry Programme, Natural Products Division, Forest Research Institute Malaysia, Kepong 52109, Malaysia.

出版信息

Molecules. 2022 Jan 18;27(3):585. doi: 10.3390/molecules27030585.

DOI:10.3390/molecules27030585
PMID:35163852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8838174/
Abstract

An alkaloid compound from the hairy root culture of has been isolated and characterised as 9-methoxycanthin-6-one. The aims of these studies were to investigate the in vitro anti-cancer activities of 9-methoxycanthin-6-one against ovarian cancer (A2780, SKOV-3), breast cancer (MCF-7), colorectal cancer (HT29), skin cancer (A375) and cervical cancer (HeLa) cell lines by using a Sulphorhodamine B assay, and to evaluate the mechanisms of action of 9-methoxycanthin-6-one via the Hoechst 33342 assay and proteomics approach. The results had shown that 9-methoxycanthin-6-one gave IC values of 4.04 ± 0.36 µM, 5.80 ± 0.40 µM, 15.09 ± 0.99 µM, 3.79 ± 0.069 µM, 5.71 ± 0.20 µM and 4.30 ± 0.27 µM when tested in A2780, SKOV-3, MCF-7, HT-29, A375 and HeLa cell lines, respectively. It was found that 9-methoxycanthin-6-one induced apoptosis in a concentration dependent manner when analysed via the Hoechst 33342 assay. 9-methoxycanthine-6-one were found to affect the expressions of apoptotic-related proteins, that were proteins pyruvate kinase (PKM), annexin A2 (ANXA2), galectin 3 (LGAL3), heterogeneous nuclear ribonucleoprotein A1 (HNRNP1A1), peroxiredoxin 3 (PRDX3), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from the differential analysis of 2-DE profiles between treated and non-treated 9-methoxycanthine-6-one. Proteins such as acetyl-CoA acyltransferase 2 (ACAA2), aldehyde dehydrogenase 1 (ALDH1A1), capping protein (CAPG), eukaryotic translation elongation factor 1 (EEF1A1), malate dehydrogenase 2 (MDH2), purine nucleoside phosphorylase (PNP), and triosephosphate isomerase 1 (TPI1) were also identified to be associated with A2780 cell death induced by 9-methoxycanthine-6-one. These findings may provide a new insight on the mechanisms of action of 9-methoxycanthin-6-one in exerting its anti-cancer effects in vitro.

摘要

从 的发根培养物中分离得到一种生物碱化合物,并鉴定为 9-甲氧基卡亭-6-酮。这些研究的目的是通过磺酰罗丹明 B 测定法研究 9-甲氧基卡亭-6-酮对卵巢癌(A2780、SKOV-3)、乳腺癌(MCF-7)、结直肠癌(HT29)、皮肤癌(A375)和宫颈癌(HeLa)细胞系的体外抗癌活性,并通过 Hoechst 33342 测定法和蛋白质组学方法评估 9-甲氧基卡亭-6-酮的作用机制。结果表明,9-甲氧基卡亭-6-酮在 A2780、SKOV-3、MCF-7、HT-29、A375 和 HeLa 细胞系中的 IC 值分别为 4.04±0.36µM、5.80±0.40µM、15.09±0.99µM、3.79±0.069µM、5.71±0.20µM 和 4.30±0.27µM。通过 Hoechst 33342 分析发现,9-甲氧基卡亭-6-酮以浓度依赖的方式诱导细胞凋亡。在差异分析中发现,9-甲氧基卡亭-6-酮处理和未处理的 9-甲氧基卡亭-6-酮之间的 2-DE 图谱,9-甲氧基卡亭-6-酮影响凋亡相关蛋白的表达,这些蛋白包括丙酮酸激酶(PKM)、膜联蛋白 A2(ANXA2)、半乳糖凝集素 3(LGAL3)、异质核核糖核蛋白 A1(HNRNP1A1)、过氧化物酶 3(PRDX3)和甘油醛-3-磷酸脱氢酶(GAPDH)。还鉴定出乙酰辅酶 A 酰基转移酶 2(ACAA2)、醛脱氢酶 1(ALDH1A1)、帽蛋白(CAPG)、真核翻译延伸因子 1(EEF1A1)、苹果酸脱氢酶 2(MDH2)、嘌呤核苷磷酸化酶(PNP)和磷酸丙糖异构酶 1(TPI1)等蛋白与 9-甲氧基卡亭-6-酮诱导的 A2780 细胞死亡有关。这些发现可能为 9-甲氧基卡亭-6-酮在体外发挥抗癌作用的作用机制提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/23eb08e5d976/molecules-27-00585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/154728f6ac1a/molecules-27-00585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/172a03ab711a/molecules-27-00585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/8aeb31a364b0/molecules-27-00585-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/9b717e45ba19/molecules-27-00585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/e3fd5eead1eb/molecules-27-00585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/23eb08e5d976/molecules-27-00585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/154728f6ac1a/molecules-27-00585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/172a03ab711a/molecules-27-00585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/8aeb31a364b0/molecules-27-00585-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/9b717e45ba19/molecules-27-00585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/e3fd5eead1eb/molecules-27-00585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e52/8838174/23eb08e5d976/molecules-27-00585-g006.jpg

相似文献

1
The In Vitro Anti-Cancer Activities and Mechanisms of Action of 9-Methoxycanthin-6-one from in Selected Cancer Cell Lines.9-甲氧基喜树碱在选定癌细胞系中的体外抗癌活性及作用机制。
Molecules. 2022 Jan 18;27(3):585. doi: 10.3390/molecules27030585.
2
longifolia, A Potential Phytomedicine for the Treatment of Cancer: Evidence of p53-mediated Apoptosis in Cancerous Cells.长叶当归,一种有潜力的癌症治疗植物药:在癌细胞中 p53 介导的细胞凋亡的证据。
Curr Drug Targets. 2018;19(10):1109-1126. doi: 10.2174/1389450118666170718151913.
3
Cytotoxic and antimalarial beta-carboline alkaloids from the roots of Eurycoma longifolia.长叶刺蒺藜根中的细胞毒性和抗疟β-咔啉生物碱。
J Nat Prod. 2003 Oct;66(10):1324-7. doi: 10.1021/np030277n.
4
Four new quassinoids from the roots of Eurycoma longifolia Jack.从长柄铁心木的根部提取的四种新的苦木苦味素。
Fitoterapia. 2014 Jan;92:105-10. doi: 10.1016/j.fitote.2013.10.009.
5
In vitro metabolism of selected bioactive compounds of Eurycoma longifolia root extract to identify suitable markers in doping control.长叶刺蒺藜根提取物中选定生物活性化合物的体外代谢,以确定兴奋剂检测中的合适标志物。
Drug Test Anal. 2019 Jan;11(1):86-94. doi: 10.1002/dta.2449. Epub 2018 Aug 9.
6
Anti-tumor activity of Eurycoma longifolia root extracts against K-562 cell line: in vitro and in vivo study.长叶补肾草药根提取物对 K-562 细胞系的抗肿瘤活性:体外和体内研究。
PLoS One. 2014 Jan 7;9(1):e83818. doi: 10.1371/journal.pone.0083818. eCollection 2014.
7
Quassinoids from the Roots of and Their Anti-Proliferation Activities.鸦胆子根中的苦木素类化合物及其抗增殖活性。
Molecules. 2021 Sep 30;26(19):5939. doi: 10.3390/molecules26195939.
8
Induction of apoptosis by Eurycoma longifolia jack extracts.长叶刺蒺藜提取物诱导细胞凋亡。
Anticancer Res. 2005 May-Jun;25(3B):2205-13.
9
Cytotoxic effects of the root extracts of Eurycoma longifolia Jack.长叶刺蒺藜树根提取物的细胞毒性作用
Phytother Res. 2005 Nov;19(11):994-6. doi: 10.1002/ptr.1759.
10
Canthin-6-one alkaloids and a tirucallanoid from Eurycoma longifolia and their cytotoxic activity against a human HT-1080 fibrosarcoma cell line.长叶刺蒺藜中的铁屎米 - 6 - 酮生物碱和三萜类化合物及其对人HT - 1080纤维肉瘤细胞系的细胞毒性活性。
Nat Prod Commun. 2010 Jan;5(1):17-22.

引用本文的文献

1
Identification of CD36 as a contributor in inflammatory response of rheumatoid arthritis and screening of feasible bioactive drugs targeting it.鉴定CD36作为类风湿性关节炎炎症反应的促成因素并筛选针对它的可行生物活性药物。
Hereditas. 2025 Jun 3;162(1):95. doi: 10.1186/s41065-025-00450-3.
2
The effects of LED Spectra on synthesis of antiparasitic bioactive compound in Eurycoma longifolia hairy root culture against Blastocystis Sp.发光二极管光谱对长叶刺蒺藜毛状根培养物中抗寄生虫生物活性化合物合成的影响,该培养物针对人芽囊原虫。
Sci Rep. 2025 Apr 26;15(1):14662. doi: 10.1038/s41598-025-99906-9.
3
Trends in the Tissue Culture Techniques and the Synthesis of Bioactive Compounds in Jack-Current Status and Future Perspectives.

本文引用的文献

1
Pharmacological Targeting of Executioner Proteins: Controlling Life and Death.执行蛋白的药物靶标:生死调控。
J Med Chem. 2021 May 13;64(9):5276-5290. doi: 10.1021/acs.jmedchem.0c02200. Epub 2021 May 3.
2
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.天然产物:1981 年 1 月至 2019 年 9 月近四十年来的新药来源
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
3
p53, cancer and the immune response.p53、癌症与免疫反应
杰克树组织培养技术及生物活性化合物合成的趋势——现状与未来展望
Plants (Basel). 2023 Dec 29;13(1):107. doi: 10.3390/plants13010107.
4
Comprehensive transcriptional analysis of pig facial skin development.猪面部皮肤发育的综合转录组分析。
PeerJ. 2023 Aug 28;11:e15955. doi: 10.7717/peerj.15955. eCollection 2023.
5
In Vitro and In Silico Analysis of the Anticancer Effects of Eurycomanone and Eurycomalactone from .来自[具体来源]的刺蒺藜皂甙和刺蒺藜内酯抗癌作用的体外和计算机模拟分析
Plants (Basel). 2023 Jul 31;12(15):2827. doi: 10.3390/plants12152827.
6
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators.康亭-6-酮:通过靶向多种炎症介质治疗慢性炎症性疾病的潜在药物。
Molecules. 2023 Apr 11;28(8):3381. doi: 10.3390/molecules28083381.
7
ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.雌激素受体β1 增敏和雌激素受体β2 脱敏 ERα 阳性乳腺癌细胞对他莫昔芬、氟维司群及其与全反式维甲酸联合的抑制作用。
Int J Mol Sci. 2023 Feb 13;24(4):3747. doi: 10.3390/ijms24043747.
8
Identification of Specific Cervical Cancer Subtypes and Prognostic Gene Sets in Tumor and Nontumor Tissues Based on GSVA Analysis.基于基因集变异分析(GSVA)在肿瘤和非肿瘤组织中鉴定特定宫颈癌亚型及预后基因集
J Oncol. 2022 Oct 15;2022:6951885. doi: 10.1155/2022/6951885. eCollection 2022.
J Cell Sci. 2020 Mar 6;133(5):jcs237453. doi: 10.1242/jcs.237453.
4
Inhibition of p53 inhibitors: progress, challenges and perspectives.p53 抑制剂的抑制:进展、挑战和展望。
J Mol Cell Biol. 2019 Jul 19;11(7):586-599. doi: 10.1093/jmcb/mjz075.
5
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.肿瘤蛋白p53调节的凋亡诱导蛋白1的过表达通过PI3K/Akt途径调节乳腺癌细胞的增殖和凋亡。
J Breast Cancer. 2019 Jun;22(2):172-184. doi: 10.4048/jbc.2019.22.e21.
6
Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?癌细胞中的糖异生作用——饥饿诱导的代谢途径的再利用?
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):24-36. doi: 10.1016/j.bbcan.2019.05.006. Epub 2019 May 30.
7
The Structural Biology of Bcl-x.Bcl-x 的结构生物学
Int J Mol Sci. 2019 May 7;20(9):2234. doi: 10.3390/ijms20092234.
8
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase.癌症中的糖异生作用:磷酸烯醇式丙酮酸羧激酶、果糖-1,6-二磷酸酶和葡萄糖-6-磷酸酶的功能与调控
Trends Cancer. 2019 Jan;5(1):30-45. doi: 10.1016/j.trecan.2018.11.003. Epub 2018 Dec 20.
9
Global cancer incidence in older adults, 2012 and 2035: A population-based study.全球老年人癌症发病率:2012 年和 2035 年的基于人群研究。
Int J Cancer. 2019 Jan 1;144(1):49-58. doi: 10.1002/ijc.31664. Epub 2018 Oct 30.
10
Annexin A2 and cancer: A systematic review.膜联蛋白 A2 与癌症:系统综述。
Int J Oncol. 2018 Jan;52(1):5-18. doi: 10.3892/ijo.2017.4197. Epub 2017 Nov 8.